Blog
Medicare GLP-1 Coverage for Weight Loss in 2026

Medicare GLP-1 coverage for weight loss changed on July 1, 2026, when the Medicare GLP-1 Bridge began. Eligible adults with a Part D plan can get Wegovy, the Zepbound KwikPen or Foundayo for weight management for $50 per one-month supply through December 31, 2027. To qualify, you need a BMI of 35 or higher, or a lower BMI with certain health conditions, plus prior authorization from your prescriber.
Before July 2026, Medicare GLP-1 coverage did not include medicines used only for weight loss. This guide explains who qualifies now, who is left out, how to apply, what happens after 2027 and the options if you do not qualify.
Medicare GLP-1 Coverage in 2026 at a Glance
The Medicare GLP-1 Bridge runs from July 1, 2026 to December 31, 2027. Eligible Part D enrollees pay $50 per one-month supply for Wegovy, the Zepbound KwikPen or Foundayo prescribed for weight management. You need a qualifying BMI, sometimes with a health condition, and prior authorization. GLP-1s for type 2 diabetes or sleep apnea may be covered by your Part D plan instead, under that plan’s rules.
Why Medicare Did Not Cover Weight Loss Drugs Before
Federal law has long excluded drugs used for weight loss from Medicare Part D. That is why Medicare GLP-1 coverage before 2026 depended on another approved use.
| GLP-1 use | Medicare coverage before July 2026 |
| Type 2 diabetes | Can be covered by Part D plans |
| Lowering heart attack and stroke risk in adults with heart disease and obesity or overweight, brand Wegovy | Can be covered by Part D plans since that use was approved |
| Moderate to severe obstructive sleep apnea with obesity, brand Zepbound | Can be covered by Part D plans since that use was approved |
| Weight loss alone | Not covered, because of the statutory exclusion |
The Bridge is a temporary program created by CMS. It does not change the law. Our guide to GLP-1s and heart health covers the heart risk use in more detail.
Who Qualifies for Medicare GLP-1 Coverage Through the Bridge
Eligibility for Medicare GLP-1 coverage through the Bridge depends on your BMI, your health conditions and your drug plan.
| BMI when you start | Health condition needed |
| 35 or higher | None |
| 30 or higher | Heart failure with preserved ejection fraction, chronic kidney disease stage 3a or higher, or high blood pressure that stays uncontrolled on two medicines |
| 27 or higher | Prediabetes, a past heart attack, a past stroke or symptomatic peripheral artery disease |
You must also be 18 or older and enrolled in a Medicare Part D plan or a Medicare Advantage plan that includes drug coverage. Your prescriber must confirm the medicine is for weight reduction alongside diet and exercise. Check your numbers first with our BMI calculator.
Who Does Not Qualify
Some groups are left out of Medicare GLP-1 coverage through the Bridge, either because they already have coverage another way or because they do not meet the criteria.
- People with type 2 diabetes. Their GLP-1 may be covered by their Part D plan instead, under that plan’s rules.
- People with obstructive sleep apnea. That use may be covered by their Part D plan.
- People already getting a GLP-1 through their drug plan. They keep that coverage instead.
- People whose only Medicare coverage is a private fee-for-service plan, a cost plan or PACE. These are not part of the Bridge.
- People with MASH, a type of fatty liver disease. Excluded from the Bridge.
- People taking a GLP-1 for heart risk reduction. That use may be covered by their Part D plan.
- People without Part D or Medicare Advantage drug coverage. The Bridge requires drug coverage.
- People with a BMI between 30 and 34.9 without a listed condition. They do not meet the criteria.
The last group is large. Many adults with obesity do not have one of the listed conditions. Our guide to what a BMI of 30 means covers why that line matters for health.
Which Drugs the Bridge Covers
Medicare GLP-1 coverage under the Bridge applies only to certain brand medicines prescribed for weight management.
| Covered under the Bridge | Not covered under the Bridge |
| Wegovy injection and Wegovy tablets | Ozempic |
| Zepbound KwikPen | Mounjaro |
| Foundayo tablets | Zepbound vials and single-dose pens, and all compounded GLP-1 medications |
Ozempic and Mounjaro are approved for type 2 diabetes, so they follow regular Part D rules. Wegovy, Zepbound, Foundayo, Ozempic and Mounjaro are trademarks of their owners, and AHC does not manufacture medications.
Mistakes That Delay Medicare GLP-1 Coverage
Small gaps in paperwork can slow a request. These are the common ones.
| Mistake | Better approach |
| Expecting to enroll yourself | Ask your prescriber to submit the prior authorization |
| Missing documentation of a qualifying condition | Bring records of conditions like prediabetes or a past heart attack |
| An old BMI on file | Get a current height and weight measured |
| Asking for a drug the Bridge does not cover | Ask which covered drug fits you |
| Guessing about Bridge rules | Call 1-800-MEDICARE with Bridge questions |
| Waiting until late 2027 | Start early, since the Bridge is set to end on December 31, 2027 |
How to Apply for Medicare GLP-1 Coverage
You do not enroll yourself for Medicare GLP-1 coverage under the Bridge. Your prescriber starts the process, and a decision usually follows the prior authorization review.
- Check your BMI and conditions. Compare them with the eligibility table above.
- Confirm your drug coverage. You need Part D or a Medicare Advantage plan with drug coverage.
- Talk to your prescriber. Ask whether you qualify and which covered medicine fits.
- Prior authorization. Your prescriber submits a request and confirms you meet the criteria.
- Fill it at your pharmacy. Once approved, you pay $50 per one-month supply, regardless of income.
Refills generally do not need a new prior authorization unless you switch to a different covered drug.
How the Bridge Costs Work
The $50 monthly copay is your cost for the covered medicine under Medicare GLP-1 coverage through the Bridge. The money rules differ from regular Part D in a few ways.
| Cost rule | What it means |
| $50 per one-month supply | Your copay for a covered GLP-1 under the Bridge, regardless of income |
| Does not count toward your Part D deductible | Bridge payments sit outside your Part D plan |
| Does not count toward the Part D out-of-pocket cap | The 2026 cap is $2,100, and Bridge copays do not add to it |
| Extra Help does not lower the $50 | Low-income subsidy rules do not apply to the Bridge |
For questions about Medicare GLP-1 coverage under the Bridge, call 1-800-MEDICARE. Bridge drugs are also not eligible for the Medicare Prescription Payment Plan.
What Happens After 2027
Medicare GLP-1 coverage beyond December 31, 2027 is not settled. The Bridge was first meant as a short gap before a Part D pilot called the BALANCE Model.
| Date | What happened |
| April 2026 | CMS delayed the Part D part of the BALANCE Model for 2027, with no new date, and extended the Bridge |
| May 2026 | BALANCE began rolling out in participating state Medicaid programs, running through 2031 |
| July 1, 2026 | The Medicare GLP-1 Bridge started |
| December 31, 2027 | The Bridge is set to end |
CMS said it is delaying BALANCE in Part D pending further evaluation and data collection. Changes from Congress or CMS could still happen, so check before the end of 2027. For the Medicaid side, see our tracker of Medicaid GLP-1 coverage by state.
Options If You Do Not Qualify for Medicare GLP-1 Coverage
Not qualifying for Medicare GLP-1 coverage under the Bridge does not leave you without choices. These are the common next steps.
| Your situation | Possible next step |
| BMI 30 to 34.9 with no listed condition | Ask your doctor whether any condition has been missed or untreated |
| Type 2 diabetes | Ask about GLP-1 coverage through your Part D plan |
| No Part D coverage | Review drug coverage during Medicare open enrollment |
| You want a cash-pay option | A cash-pay telehealth program is another route |
Our guide to checking GLP-1 insurance coverage lists questions to ask any plan. For age-related points, see GLP-1 after 50.
Where AHC Fits for Medicare Members
AHC is cash-pay only. It does not bill Medicare, Medicaid or private insurance, and HSA and FSA cards are not accepted. If you have Medicare and are weighing a cash-pay route, contact AHC support before you start.
| Medicare GLP-1 Bridge | AHC cash-pay |
| Brand Wegovy, Zepbound KwikPen or Foundayo | Compounded semaglutide or compounded tirzepatide |
| Needs Part D or Medicare Advantage drug coverage | Cash-pay only, not billed to Medicare |
| Prior authorization from your prescriber | An online medical intake reviewed by an AHC provider |
| Set BMI and condition criteria | A licensed provider reviews your intake and health history |
Payment is made when you submit the intake. If approved, dosage instructions arrive by email and orders ship by cold chain express shipping within the United States. Our weight loss calculator helps set a starting point to discuss.
| About compounded medication Compounded semaglutide and compounded tirzepatide are prepared by state-licensed pharmacy partners held to the same quality and safety standards. They are not FDA-approved and have not been reviewed by the FDA for safety, efficacy or quality. |
This guide is general information, not insurance or legal advice. Medicare rules change, so confirm details with Medicare or your plan. Results vary by individual and depend on adherence, clinical guidance and lifestyle factors.
| Not sure which route fits? A provider consultation costs $29.99. Learn about AHC’s program and how AHC providers review each case. |
Frequently Asked Questions
Does Medicare cover GLP-1s for weight loss in 2026?
Yes, for some people. The Medicare GLP-1 Bridge gives Medicare GLP-1 coverage for weight management from July 1, 2026 to December 31, 2027, if you meet the BMI and condition criteria.
How much does the Medicare GLP-1 Bridge cost?
Eligible members pay $50 per one-month supply for a covered medicine. That copay does not count toward the Part D out-of-pocket cap.
Does Medicare cover Ozempic for weight loss?
No. Ozempic is covered through Part D for type 2 diabetes. The Bridge covers Wegovy, the Zepbound KwikPen and Foundayo for weight management.
Does AHC accept Medicare?
No. AHC is cash-pay only and does not bill Medicare, Medicaid or private insurance. HSA and FSA cards are not accepted.
Can I use AHC if I am on Medicare?
Contact AHC support before you start so your situation can be reviewed. AHC is cash-pay only and does not bill Medicare. Approval is never guaranteed.
Does the Medicare GLP-1 Bridge cover compounded medication?
No. Medicare GLP-1 coverage under the Bridge applies only to the listed brand medicines.
Can AHC give me paperwork for reimbursement?
AHC can provide a letter of medical necessity. Whether any plan reimburses you is up to that plan, and AHC does not file claims.
What if I do not qualify for the Bridge?
Ask your doctor about Part D coverage for other approved uses. If you are weighing a cash-pay route, contact AHC support first.
Can I talk to an AHC provider before choosing?
Yes. A provider consultation costs $29.99. It is a good time to compare Medicare GLP-1 coverage with a cash-pay route.
Who reviews my request at AHC?
An AHC provider reviews your intake and health history. Approval is never guaranteed.
Tools to Plan Your Next Step
Two more free tools help you prepare for a conversation with your doctor or AHC provider.
- TDEE calculator. Estimate your daily energy needs before you start treatment.
- GLP-1 protein calculator. Set a protein target that helps protect muscle as you age.
Questions about your options? Speak with an AHC provider for $29.99.
Medical Disclaimer
This content is for informational purposes only and is not medical advice. Compounded medications are prepared by state-licensed pharmacy partners. They are not FDA-approved and have not been reviewed by the FDA for safety, efficacy or quality. Prescriptions are issued by independently contracted, U.S.-licensed clinicians following an individual medical review, and approval is never guaranteed. Results vary by individual and depend on adherence, clinical guidance, and lifestyle factors. For questions about your treatment, contact AHC support through live chat on the website or at [email protected]. If you have severe symptoms, seek medical care.